葡萄柚籽提取物和木糖醇Xlear可杀死和/或灭活SARS-CoV-2 可有效抵御新的变异病毒

2021-01-28 国际文传 国际文传

Xlear的成分(葡萄柚籽提取物和木糖醇)可显著杀灭COVID-19致病病毒SARS-CoV-2

犹他州立大学和西北大学合作完成的一项新的体外研究发现,Xlear的成分(葡萄柚籽提取物和木糖醇)可显著杀灭COVID-19致病病毒SARS-CoV-2。影像学研究部分是在西北大学NUANCE中心BioCryo实验室开展的。

该研究对使用单一浓度Xlear鼻腔喷雾剂后的SARS-CoV-2病毒滴度和LRV进行了测试。研究显示,“接触时间25分钟后,鼻腔喷雾剂将病毒从4.2 log10 CCID50/0.1 mL降至1.7 log10 CCID50/0.1 mL,降幅为2.5 log10 CCID50/0.1 mL,差异(P<0.001)具有统计学意义。”西北大学/犹他州立大学的这项研究是一系列研究中的最新研究,结论是Xlear可有效抵御SARS-CoV-2。

不过,该研究在两个重要方面实现新突破,西北大学费恩伯格医学院教授Mark Cannon博士表示:“首先,我们的结论是,除了抵御SARS-CoV-2,Xlear还可能有效防止未来的H1N1病毒的传播,包括新发的SARS-CoV-2变异病毒,以及其他病毒性流行病。鉴于我们现在面临的变异病毒传播性更强,该结论至关重要。其次,使用电子显微镜,我们有视觉证据显示,木糖醇和GSE能够抵御该病毒。GSE可杀死病毒,而木糖醇可阻止病毒附着于细胞壁。附图显示,SARS-CoV-2病毒位于细胞外侧且从未附着,感染因此得以阻止。”该研究假设,木糖醇作为SARS-CoV-2的诱饵目标,阻止病毒附着于细胞壁上的核心蛋白。

此次协作研究得出的结论是:“由于使用X/GSE组合疗法不存在危险因素,[Xlear]鼻腔喷雾剂无需处方即可在柜台出售,且[Xlear]不影响长时间舒适地佩戴口罩,因此应鼓励采纳这种预防性的抗病毒治疗。”

研究全文:https://www.biorxiv.org/content/10.1101/2020.12.02.408575v3.full

阅读原文:http://www.businesswirechina.com/zh/news/45604.html

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1937986, encodeId=b703193e986ec, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Mon Jul 19 21:23:20 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010906, encodeId=39452010906c5, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Thu Apr 22 04:23:20 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321252, encodeId=dcad1321252d6, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342774, encodeId=108b1342e74e3, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921195, encodeId=0c0792119558, content=有点神奇, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Jan 29 20:43:04 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-07-19 hukaixun
  2. [GetPortalCommentsPageByObjectIdResponse(id=1937986, encodeId=b703193e986ec, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Mon Jul 19 21:23:20 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010906, encodeId=39452010906c5, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Thu Apr 22 04:23:20 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321252, encodeId=dcad1321252d6, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342774, encodeId=108b1342e74e3, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921195, encodeId=0c0792119558, content=有点神奇, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Jan 29 20:43:04 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1937986, encodeId=b703193e986ec, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Mon Jul 19 21:23:20 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010906, encodeId=39452010906c5, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Thu Apr 22 04:23:20 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321252, encodeId=dcad1321252d6, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342774, encodeId=108b1342e74e3, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921195, encodeId=0c0792119558, content=有点神奇, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Jan 29 20:43:04 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-01-30 小刀医生
  4. [GetPortalCommentsPageByObjectIdResponse(id=1937986, encodeId=b703193e986ec, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Mon Jul 19 21:23:20 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010906, encodeId=39452010906c5, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Thu Apr 22 04:23:20 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321252, encodeId=dcad1321252d6, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342774, encodeId=108b1342e74e3, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921195, encodeId=0c0792119558, content=有点神奇, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Jan 29 20:43:04 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1937986, encodeId=b703193e986ec, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Mon Jul 19 21:23:20 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010906, encodeId=39452010906c5, content=<a href='/topic/show?id=a69c381136d' target=_blank style='color:#2F92EE;'>#变异病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38113, encryptionId=a69c381136d, topicName=变异病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Thu Apr 22 04:23:20 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321252, encodeId=dcad1321252d6, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342774, encodeId=108b1342e74e3, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 30 07:23:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921195, encodeId=0c0792119558, content=有点神奇, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Jan 29 20:43:04 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-01-29 T2DM终结者

    有点神奇

    0

相关资讯

Clin Exp Otorhinolaryngol:人鼻病毒感染可增强慢性鼻窦炎过敏和非过敏患者的Th2环境

在近期发表在Clin Exp Otorhinolaryngol期刊的一项研究中,来自韩国首尔大学等单位的科学家们研究了过敏患者是否更容易受到人鼻病毒(HRV)感染,以及在过敏体质和非过敏体质的慢性鼻窦

全新测试结果证明,首尔伟傲世的Violeds模块可杀灭99%的空气传播病毒

首尔伟傲世(KOSDAQ: 092190)韩国测试实验室(KTL)的测试结果证明,装有该公司紫外线LED Violeds模块的空调和供暖系统可杀灭99%的空气传播病毒

海关总署:对检出新冠病毒的进口冷链食品境外生产商实施紧急预防性措施

9月11日下午,海关总署发布《对检出新冠病毒核酸阳性的进口冷链食品境外生产企业实施紧急预防性措施的公告》:

Lancet Infect Dis :导致关节炎的α病毒——新兴虫媒病毒的流行病学和临床前景

蚊子传播的病毒,也被称为虫媒病毒,几个世纪以来一直是传染病的重要组成部分,并且经常是世界赤道和亚热带地区的地方病。最近的疫情进一步凸显了这些病毒造成的巨大公共卫生负担。

新冠动态丨Cell子刊发表研究:新冠病毒D614G突变不仅没有影响疫苗保护效果,反而对疫苗更敏感!

新冠病毒持续在全球肆虐,新增感染人数屡创新高,全球抗疫的任务依然异常艰巨。好在最近关于疫苗的好消息不断出现,辉瑞/BioNTech和Moderna先后公布了三期临床实验中期分析结果,疫苗的有效性均大于

AP&T: 乙型肝炎病毒RNA下降而无病毒性抗原下降与持续应答和乙型肝炎表面抗原丢失的可能性低相关

慢性乙型肝炎(CHB)感染是造成终末期肝病和肝细胞癌(HCC)的主要原因之一。